Download PDF
Aktuelle Dermatologie 2011; 37(3): 75-80
DOI: 10.1055/s-0030-1256156
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Behandlung von Keloiden

Current Therapeutic Approaches for the Treatment of KeloidsG.  G.  Gauglitz1
  • 1Klinik für Dermatologie und Allergologie der Ludwig-Maximilian-Universität München
Further Information

Publication History

Publication Date:
10 March 2011 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Keloide bilden sich meist nach operativ oder traumatisch entstandenen Wunden. Sie werden zusätzlich nach Tätowierungen, Piercings und in Folge lang anhaltender, entzündlicher Erkrankungen der Haut beobachtet. Eine genetische Disposition wird diskutiert. Besonders gefährdete Regionen sind die vordere Brustregion, die Schulterpartie und die Ohrläppchen. Bei disponierten Personen können Keloide sogar spontan entstehen. Trotz vieler verschiedener Therapiekonzepte und Studien zur Behandlung von Keloiden, gestaltet sich deren Therapie aufgrund der hohen Rezidivrate nach wie vor schwierig. Neben etablierten Techniken zur Vorbeugung und Behandlung von Keloiden werden heute neuere, weniger etablierte Verfahren (Farbstofflaser, Imiquimod), zum Teil in Kombination, erfolgreich eingesetzt.

Abstract

Keloids may arise following any insult to the deep dermis or develop after minor injuries and may even form spontaneously on the mid-chest in the absence of any known injury. In the majority of cases, keloids develop in wounds at anatomic locations with high tension, such as anterior chest, shoulders and earlobes. Multiple studies on keloid formation have been conducted for decades and have led to a plethora of therapeutic strategies in order to prevent or attenuate excessive scar formation. However, most therapeutic approaches remain clinically unsatisfactory, mostly due to the high recurrence rates of keloids. Besides well known therapeutic approaches, today, emerging treatment strategies including pulsed dye laser and imiquimod crème extend the spectrum of keloid therapy.

Literatur

  • 1 Marneros A G, Krieg T. Keloids – clinical diagnosis, pathogenesis, and treatment options.  J Dtsch Dermatol Ges. 2004;  2 905-913
    PubMedGoogle Scholar
  • 2 Karrer S. [Therapy of keloids].  Hautarzt. 2007;  58 979-989
    CrossrefPubMedGoogle Scholar
  • 3 Lu L, Saulis A S, Liu W R et al. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation.  J Am Coll Surg. 2005;  201 391-397
    CrossrefPubMedGoogle Scholar
  • 4 Deitch E A, Wheelahan T M, Rose M P et al. Hypertrophic burn scars: analysis of variables.  J Trauma. 1983;  23 895-898
    CrossrefPubMedGoogle Scholar
  • 5 Baisch A, Riedel F. [Hyperplastic scars and keloids. Part I: basics and prevention].  HNO. 2006;  54 893-904
    CrossrefPubMedGoogle Scholar
  • 6 Gassner H G, Sherris D A, Otley C C. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates.  Plast Reconstr Surg . 2000;  105 1948-1953
    CrossrefPubMedGoogle Scholar
  • 7 Mustoe T A, Cooter R D, Gold M H et al. International clinical recommendations on scar management.  Plast Reconstr Surg. 2002;  110 560-571
    CrossrefPubMedGoogle Scholar
  • 8 Slemp A E, Kirschner R E. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.  Curr Opin Pediatr. 2006;  18 396-402
    CrossrefPubMedGoogle Scholar
  • 9 Phan T T, Lim I J, Sun L et al. Quercetin inhibits fibronectin production by keloid-derived fibroblasts. Implication for the treatment of excessive scars.  J Dermatol Sci. 2003;  33 192-194
    CrossrefPubMedGoogle Scholar
  • 10 Ho W S, Ying S Y, Chan P C, Chan H H. Use of onion extract, heparin, allantoin gel in prevention of scarring in Chinese patients having laser removal of tattoos: a prospective randomized controlled trial.  Dermatol Surg. 2006;  32 891-896
    CrossrefPubMedGoogle Scholar
  • 11 Koc E, Arca E, Surucu B, Kurumlu Z. An Open, Randomized, Controlled, Comparative Study of the Combined Effect of Intralesional Triamcinolone Acetonide and Onion Extract Gel and Intralesional Triamcinolone Acetonide Alone in the Treatment of Hypertrophic Scars and Keloids.  Dermatologic Surgery. 2008;  34 1507-1514
    CrossrefPubMedGoogle Scholar
  • 12 Danneberg S D. Fast effects with a scar gel under therapeutic ultrasound: Results of a single-centre investigation.  Cosmetic Medicine. 2007;  3 133-138
    PubMedGoogle Scholar
  • 13 Koller J. Therapie pathologischer Narben (hypertrophe Narben und Keloide).  Leitlinie. JDDG. 2004;  2 308-312
    CrossrefPubMedGoogle Scholar
  • 14 Ernst K, Hundeiker M. Results of cryosurgery in 394 patients with hypertrophic scars and keloids.  Hautarzt. 1995;  46 462-466
    CrossrefPubMedGoogle Scholar
  • 15 Sharpe D. Of apples and oranges, file drawers and garbage: why validity issues in meta-analysis will not go away.  Clin Psychol Rev Dec. 1997;  17 881-901
    PubMedGoogle Scholar
  • 16 Atiyeh B S. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods.  Aesthetic Plast Surg. 2007;  31 468-494
    CrossrefPubMedGoogle Scholar
  • 17 Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature.  Arch Facial Plast Surg. 2006;  8 362-368
    CrossrefPubMedGoogle Scholar
  • 18 Tang Y W. Intra- and postoperative steroid injections for keloids and hypertrophic scars.  Br J Plast Surg. 1992;  45 371-373
    CrossrefPubMedGoogle Scholar
  • 19 Hackert I, Aschoff R, Sebastian G. [The treatment of keloids].  Hautarzt. 2003;  54 1003-1015
    CrossrefPubMedGoogle Scholar
  • 20 Baisch A, Riedel F. [Hyperplastic scars and keloids: part II: Surgical and non-surgical treatment modalities].  HNO. 2006;  54 981-992
    CrossrefPubMedGoogle Scholar
  • 21 Arco G HRE. Chirurgie der Narben.  Chirurgische Allgemeine. 2009;  10 17-28
    PubMedGoogle Scholar
  • 22 De Lorenzi F, Tielemans H J, van der Hulst R R et al. Is the treatment of keloid scars still a challenge in 2006?.  Ann Plast Surg. 2007;  58 186-192
    CrossrefPubMedGoogle Scholar
  • 23 Hoffman S. Radiotherapy for keloids.  Ann Plast Surg. 1982;  9 265
    CrossrefPubMedGoogle Scholar
  • 24 Caccialanza M, Piccinno R, Schiera A. Postoperative radiotherapy of keloids: a twenty-year experience.  Eur J Dermatol. 2002;  12 58-62
    PubMedGoogle Scholar
  • 25 Alster T. Laser scar revision: comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids.  Dermatol Sur. 2003;  29 25-29
    PubMedGoogle Scholar
  • 26 Bouzari N, Davis S C, Nouri K. Laser treatment of keloids and hypertrophic scars.  Int J Dermatol. 2007;  46 80-88
    CrossrefPubMedGoogle Scholar
  • 27 Kumar K, Kapoor B S, Rai P, Shukla H S. In-situ irradiation of keloid scars with Nd:YAG laser.  J Wound Care. 2000;  9 213-215
    PubMedGoogle Scholar
  • 28 Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5 % cream on the recurrence rate of excised keloids.  J Am Acad Dermatol. 2002;  47 209-211
    CrossrefPubMedGoogle Scholar
  • 29 Patel P J, Skinner Jr R B. Experience with keloids after excision and application of 5 % imiquimod cream.  Dermatol Surg. 2006;  32 462
    CrossrefPubMedGoogle Scholar
  • 30 Martin-Garcia R F, Busquets A C. Postsurgical use of imiquimod 5 % cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study.  Dermatol Surg. 2005;  31 1394-1398
    CrossrefPubMedGoogle Scholar
  • 31 Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars.  Australas J Dermatol. 2004;  45 140-143
    CrossrefPubMedGoogle Scholar
  • 32 Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures.  Dermatol Surg. 2001;  27 23-27
    CrossrefPubMedGoogle Scholar
  • 33 Fitzpatrick R E. Treatment of inflamed hypertrophic scars using intralesional 5-FU.  Dermatol Surg. 1999;  25 224-232
    CrossrefPubMedGoogle Scholar
  • 34 Tredget E E, Shankowsky H A, Pannu R et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b.  Plast Reconstr Surg. 1998;  102 1317-1328
    CrossrefPubMedGoogle Scholar
  • 35 Mutalik S. Treatment of keloids and hypertrophic scars.  Indian J Dermatol Venereol Leprol. 2005;  71 3-8
    CrossrefPubMedGoogle Scholar

Dr. med. Gerd G. Gauglitz, MMS 

Klinik für Dermatologie und Allergologie der Ludwig-Maximilian-Universität München

Frauenlobstraße 9 – 11
80337 München

Email: gerd.gauglitz@med.uni-muenchen.de